Oncology Zoledronic Acid infusion
Overview
This programme provides funding for Zoledronic acid infusions to patients with cancer related conditions who would benefit from this treatment. In most instances this infusion will be requested of general practice by the patient's oncologist.
The infusion is to be provided in the community by the patient’s general practitioner.
This service is part of the Advanced Primary Options programme.
Your Pinnacle Services Contract applies to this service. By claiming for this service, you have indicated that you have read and agreed to the business rules set out here.
This is NOT a clinical guideline.
